Homocysteine PF - Jarrow Formulas
Reduces Homocysteine to Methionine
Homocysteine PF
 Size 100 Easy-Solv Tabs
*Retail Price $14.95
 Our Price: $10.71 (Save 28%)
 SKU No. METH
 Prod. No. 1732
 UPC Code:790011200062
Bullet Description
Homocysteine PF (Protection Factors) contains methyl group (CH3) donors from Methyl B12, TMG and Folic Acid, plus vitamin B6 for additional reduction of homocysteine. Methyl groups convert homocysteine, a toxic amino acid, into methionine, which is an essential amino acid. Methylation is inhibited by poor diet (excessive protein and fat intake or inadequate nutrition), alcohol, caffeine, smoking and genetic predisposition. Impaired methylation elevates homocysteine levels. Methylcobalamin (Methyl B12) is better absorbed, retained and utilized than cyanocobalamin, the typical form of vitamin B12. Methylfolate transfers a methyl group to cobalamin to form Methylcobalamin via the enzyme methionine synthetase. Therefore, Methyl B12 is the most active and most important form of B12.

 
Bullet Suggested Use
Take 1 tablet daily with a meal, or as directed by your qualified health consultant. Easy-Solv tablets disintegrate within several minutes of ingestion.
 
Bullet Ingredients/Supplement Facts
Supplement Facts
Serving Size 1 Tablet

Ingredients Amount %DV

Vitamin B6 (Pyridoxine HCl) 15 mg 750%
Vitamin B12 (Methylcobalamin) 250 mcg 4167%
Folic Acid 400 mcg 100%
Trimethylglycine (TMG) (Anhydrous Betaine) 500 mg

Other Ingredients: Cellulose, dicalcium phosphate, stearic acid (vegetable source), modified cellulose gum, magnesium stearate and silcon dioxide.
Easy-Solv tablets dissolve within minutes of ingestion.

†: Daily value not established.
 
Bullet Warning
Keep out of the reach of children.
 

  Jarrow Formulas - Homocysteine PF  100 Easy-Solv Tabs

Disclaimer
The price and availability of this product may vary after a time period and it is subjected to any update, company does in the above mentioned regards. Same Day Shipping is subjected to the stock status of product and may change anytime.